Ret Proto-Oncogene Antikörper (AA 881-930)
Kurzübersicht für Ret Proto-Oncogene Antikörper (AA 881-930) (ABIN1450578)
Target
Alle Ret Proto-Oncogene (RET) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 881-930
-
Spezifität
-
Ret Antibody detects endogenous levels of total Ret protein.
-
Aufreinigung
- The antibody was purified from rabbit antiserum by affinity-chromatography using immunogen.
-
Immunogen
- The antiserum was produced against synthesized peptide derived from human RET.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500~1:1000 IHC: 1:50~1:100 IF: 1:100~1:500 ELISA: 1:1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable at -20°C for at least 1 year.
-
-
- Ret Proto-Oncogene (RET)
-
Andere Bezeichnung
- Ret
-
Hintergrund
-
Synonyms: C-ret, kinase Ret, Proto-oncogene ret precursor
NCBI Gene Symbol: RET
-
Molekulargewicht
- 124 kDa
-
Gen-ID
- 5979
-
OMIM
- 114500
-
UniProt
- P07949
-
Pathways
- RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Target
-